"The guest argued that investors should focus on simple, consistent cash-flow businesses in the consumer sector rather than high-beta, cyclical discretionary names."

"The guest argued that the rise of GLP-1 weight loss drugs like Ozempic is driving a surprising surge in demand for mints and gum due to a side effect known as 'Ozempic breath.'"